This platform provides Research Use Only (RUO) biochemical materials. By proceeding, you confirm and attest the following:
Research Use Only · Not for human consumption · Not FDA evaluated

Empirical-grade lyophilized peptides with full Certificates of Analysis. Procure via cryptographic settlement.
Every batch undergoes rigorous third-party analytical testing to confirm identity, purity, and mass. Each product is verified to be the correct peptide via HPLC and mass spectrometry, with purity above 99% and net peptide content above 90%. View the COA section for full Certificates of Analysis.
Triple Agonist GLP3 is a research peptide that activates the GLP-1, GIP, and glucagon receptors. It is studied primarily for its effects on appetite regulation, energy expenditure, and significant body weight reduction. By stimulating the GLP-1 and GIP pathways, Triple Agonist GLP3 helps reduce food noise and improve satiety, while the glucagon receptor activation is believed to increase energy expenditure and support the breakdown of stored fat, including visceral fat. Research has shown it produces substantial weight loss, often greater than dual or single agonists, making it a compound of high interest for metabolic and obesity-related studies.
View Full ProfileFDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.